Purpose To present a case of struma ovarii with a typical features and synchronous primary
thyroid carcinoma and review the available literature to guide diagnosis and management of …

Malignant transformation occurs in 1.5-2% of mature cystic teratomas (MCT) s of the ovary
and usually consists of squamous cell carcinoma, whereas other malignancies are less …

Aim To evaluate the clinico‐pathologic features, treatment options, prognostic factors, and
survival outcomes of malignant struma ovarii based on a systematic literature review in …

Background Malignant struma ovarii (MSO) is a very rare, germ cell tumor of the ovary,
histologically identical to differentiated thyroid cancers. Struma ovarii (SO) is difficult to …

Background/Aim: The aim of the study was to assess the clinical outcome of patients with
malignant transformation of an ovarian mature teratoma. Patients and Methods: This study …

Objective. To present a rare case of malignant struma ovarii (MSO) and synchronous thyroid
cancer, review the medical literature, and present the latest trends in management. Methods …

Malignant struma ovarii (MSO) with synchronous primary thyroid cancer in the neck is
extremely rare and lacks a treatment consensus. A 44‑year‑old woman presenting with a left …

Background Struma ovarii is an unusual ovarian teratoma containing predominantly thyroid
tissue. Less than 10% of cases undergo malignant transformation in the thyroid tissue and …

Background: Struma ovarii is a rare tumor, a type of ovarian mature teratoma consisting over
50% of its mass in thyroid ectopic tissue; 5% to 10% of cases, as described in the literature …

Background Struma ovarii refers to rare mature cystic teratomas containing at least 50% of
thyroid tissue, and malignant transformation is known to be even rarer. The synchronous …